רקומבינאט IU 1000

Ülke: İsrail

Dil: İbranice

Kaynak: Ministry of Health

Aktif bileşen:

COAGULATION FACTOR VIII RECOMBINANT 1000 IU/VIAL

Mevcut itibaren:

TEVA MEDICAL MARKETING LTD.

ATC kodu:

B02BD02

Farmasötik formu:

POWDER FOR SOLUTION FOR INJECTION

Uygulama yolu:

I.V

Tarafından üretildi:

BAXTER S.A., BELGIUM

Terapötik grubu:

COAGULATION FACTOR VIII

Terapötik endikasyonlar:

The use of Recombinate is indicated in the treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). Recombinate is also indicated in the perioperative management of patients with haemophilia A. Recombinate is appropriate for use in children of all ages including the newborn. (Safety and efficacy studies have been performed in both previously treated and previously untreated children). The product in not suitable for the treatment of von Willebrand's disease.

Yetkilendirme tarihi:

2010-07-01